Cargando…
Systemic AAV6-synapsin-GFP administration results in lower liver biodistribution, compared to AAV1&2 and AAV9, with neuronal expression following ultrasound-mediated brain delivery
Non-surgical gene delivery to the brain can be achieved following intravenous injection of viral vectors coupled with transcranial MRI-guided focused ultrasound (MRIgFUS) to temporarily and locally permeabilize the blood–brain barrier. Vector and promoter selection can provide neuronal expression in...
Autores principales: | Weber-Adrian, Danielle, Kofoed, Rikke Hahn, Silburt, Joseph, Noroozian, Zeinab, Shah, Kairavi, Burgess, Alison, Rideout, Shawna, Kügler, Sebastian, Hynynen, Kullervo, Aubert, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820310/ https://www.ncbi.nlm.nih.gov/pubmed/33479314 http://dx.doi.org/10.1038/s41598-021-81046-5 |
Ejemplares similares
-
Transgene distribution and immune response after ultrasound delivery of rAAV9 and PHP.B to the brain in a mouse model of amyloidosis
por: Kofoed, Rikke Hahn, et al.
Publicado: (2021) -
Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease
por: Weber-Adrian, Danielle, et al.
Publicado: (2019) -
The engineered AAV2-HBKO promotes non-invasive gene delivery to large brain regions beyond ultrasound targeted sites
por: Kofoed, Rikke Hahn, et al.
Publicado: (2022) -
AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018) -
Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
por: Weber, Thomas
Publicado: (2021)